"Buy" rating from a German web site. Not sure what to make of it, but it is interesting...
Share News. The present analysis deals with the share Pharmagreen Biotech, which is managed in the segment "trading companies and distributors". The stock closed trading on 09/07/2018 with $ 2.49. How Pharmagreen Biotech currently is to be assessed results from a multi-stage analysis. We have selected 4 categories, each leading to the result "buy", "hold" or "sell". These results are finally consolidated to the overall result. 1. Investors: A look at the discussion in social media shows the following picture: Over the last few days, market participants have generally been largely positive towards Pharmagreen Biotech. The discussion focused on positive topics for 13 days, with no negative discussion. One day, investors were more neutral. The latest news from the past one to two days about the company are also mainly positive. Based on our sentiment analysis, Pharmagreen Biotech therefore receives a "buy" estimate. Overall, Pharmagreen Biotech receives a "buy" rating from the editorial staff for investor sentiment.
News 
Market Data 
Discover 
